StockData

NextCure, Inc. (NXTC) stock

NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$6.70+0.02 (+0.30%)

Close on Nov 17, 2026Market cap $30.67MP/E –Yield 0.00%

NextCure price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

NextCure's price to book ratio was 2.0× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.2× to 2.1×, with a median of 0.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.0×+0.4
2025Dec 31, 20251.6×+1.3
2024Dec 31, 20240.3×+0.0
2023Dec 29, 20230.3×+0.0
2022Dec 30, 20220.2×−0.5
2021Dec 31, 20210.7×−0.3
2020Dec 31, 20201.0×−6.5
2019Dec 31, 20197.5×–

More NextCure figures

See a number that looks wrong?